Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries
Open Access
- 1 May 2020
- journal article
- editorial
- Published by Elsevier BV in The Lancet Rheumatology
- Vol. 2 (5), E250-E253
- https://doi.org/10.1016/S2665-9913(20)30095-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19Annals of Internal Medicine, 2020
- COVID-19 infection and rheumatoid arthritis: Faraway, so close!Autoimmunity Reviews, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionLancet, 2020
- Biologics registers in RA: methodological aspects, current role and future applicationsNature Reviews Rheumatology, 2017
- Biologic Therapies in Rheumatoid Arthritis and the Risk of Opportunistic Infections: A Meta-analysisClinical Infectious Diseases, 2014
- Infections and Biologic Therapy in Rheumatoid ArthritisRheumatic Disease Clinics of North America, 2012
- The Risk of Infections with Biologic Therapies for Rheumatoid ArthritisSeminars in Arthritis and Rheumatism, 2010
- Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome.1994